CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 263 enrolled
Drug / intervention
Stannous Fluoride dentifice +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02751450
NCT02751450N/ACompleted

A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

GlaxoSmithKline·interventional·Posted Apr 26, 2016·Updated May 17, 2017

In Brief

A clinical study evaluating Stannous Fluoride dentifice and Sodium Monofluorophosphate dentifrice for Dentin Sensitivity. Completed, enrolled 263 participants across 1 site.

Detailed Summary

This single centre, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 26, 2016
Enrollment StartFeb 1, 2016
Primary CompletionMay 1, 2016
Study CompletionJun 17, 2016
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.2 years ago

Interventions

Stannous Fluoride dentificedevice

Experimental dentifrice containing 0.454% w/w stannous fluoride (1100ppm)

Sodium Monofluorophosphate dentifriceother

Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)